We recently hosted an engaging session on the eight pillars of AI readiness for commercial life sciences organizations—powering the future of life sciences commercialization through smarter, more strategic adoption of AI. With insights from 40 companies, the discussion revealed both the opportunities and challenges of embracing AI in this space. Key takeaways from our live readiness assessment: 🔍 Many organizations are just beginning their AI journey, especially in areas like governance and understanding the investment value of AI.   ✅ Use case maturity and change management are emerging as strengths, though most companies still consider themselves in the “developing” phase.   📊 Overall, 80% of participants rated their AI-readiness as “initial” or “early developing.” We’re excited to continue the conversation. If your team is exploring how to assess and accelerate AI-readiness, we’d love to connect and share how our tailored approach—grounded in stakeholder-specific insights—can help. Connect Today, Own Tomorrow. Reach out to learn more or start a dialogue: https://bit.ly/3KcGyjE Don’t miss our next webinar: Will AI Redefine Life Sciences? 2026 Predictions | Register here: https://lnkd.in/emYEe4vA Shriram (Shri) Salem, Kaiwen Zhong, Steven Laux